23andMe, Regeneron and Biotechnology
Digest more
The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its debut. This year's event has significantly expanded its scope, offering an even richer array of content,
1h
The Business & Financial Times on MSNGhana needs bold thinkers to achieve food security – OFAB GhanaBy Nana Yaw Reuben Jr.The Open Forum on Agricultural Biotechnology in Africa a non-governmental organization fostering dialogue on agricultural biotechnology to enhance food security and economic growth across the country has encouraged students to choose courses in relation to biotechnology as a panacea to help achieve food security in our country.
Discover upcoming breakthroughs in Type 1 Diabetes & B-cell disorder treatments, market growth to $24B by 2031, and key trials expected by 2025-2026.
Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy.
The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school students. The program was launched last year after high school students from Reno who attended the 2024 Biotechnology Symposium expressed interest in a biotechnology immersion opportunity.
Explore more
Franklin Biotechnology Discovery Fund's Q1 2025 report covers market trends, key holdings, risks, and outlook—essential investor insights. Click here to read more.
Stellenbosch University (SU) has announced the opening of the LaunchLab CERIBIO, a biotechnology laboratory for biotechnology startups. The initiative aims to accelerate the local biotechnology sector,
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Tuesday, May 13, 2025. Let’s take a closer look at their individual scores to see how they measure up against each other and the Biotechnology industry median.
A groundbreaking $44 million federal biotechnology grant that would have benefited several Birmingham institutions has been cancelled. The Birmingham Biotechnology Hub, led by Southern Research, was to receive funding to use artificial intelligence to shorten drug development and provide affordable drugs,